Fingerprint
Dive into the research topics where Ana karen Nunez Cortes is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Research output
- 24 Article
-
CD70-Targeting CAR NK Cells Overcome BCMA Downregulation and Improve Survival in High-risk Multiple Myeloma Models
Lin, P., Acharya, S., Reyes-Silva, F., Basar, R., Uprety, N., Moreno Rueda, L. Y., Lin, P., Gilbert, A. L., Banerjee, P. P., Fang, D., Zhang, C., Nunez Cortes, A. K., Melo Garcia, L., Daher, M., Muniz-Feliciano, L., Deyter, G. M., Woods, V., Rawal, S., Li, P. & Jones, C. M. & 9 others, , Mar 4 2026, In: Blood Cancer Discovery. 7, 2, p. 234-249 16 p.Research output: Contribution to journal › Article › peer-review
Open Access3 Link opens in a new tab Scopus citations -
CREM is a regulatory checkpoint of CAR and IL-15 signalling in NK cells
Rafei, H., Basar, R., Acharya, S., Hsu, Y. S., Liu, P., Zhang, D., Bohn, T., Liang, Q., Mohanty, V., Upadhyay, R., Li, P., Phadatare, P., Dede, M., Xiong, D., Fan, H., Jones, C. M., Kunz, S., Daher, M., Nunez Cortes, A. K. & Shanley, M. & 38 others, , Jul 24 2025, In: Nature. 643, 8073, p. 1076-1086 11 p.Research output: Contribution to journal › Article › peer-review
Open Access32 Link opens in a new tab Scopus citations -
Genome-wide CRISPR screens identify critical targets to enhance CAR-NK cell antitumor potency
Biederstädt, A., Basar, R., Park, J. M., Uprety, N., Shrestha, R., Reyes Silva, F., Dede, M., Watts, J., Acharya, S., Xiong, D., Liu, B., Daher, M., Rafei, H., Banerjee, P., Li, P., Islam, S., Fan, H., Shanley, M., Jin, J. & Kumar, B. & 16 others, , Nov 10 2025, In: Cancer cell. 43, 11, p. 2069-2088.e11Research output: Contribution to journal › Article › peer-review
Open Access20 Link opens in a new tab Scopus citations -
Overcoming CD226-related immune evasion in acute myeloid leukemia with CD38 CAR-engineered NK cells
Melo Garcia, L., Gangadharan, A., Banerjee, P., Li, Y., Zeng, A. G. X., Rafei, H., Lin, P., Kumar, B., Acharya, S., Daher, M., Muniz-Feliciano, L., Deyter, G. M., Dominguez, G., Park, J. M., Reyes Silva, F., Nunez Cortes, A. K., Basar, R., Uprety, N., Shanley, M. & Kaplan, M. & 3 others, , Jan 28 2025, In: Cell Reports. 44, 1, 115122.Research output: Contribution to journal › Article › peer-review
Open Access8 Link opens in a new tab Scopus citations -
BATF is a major driver of NK cell epigenetic reprogramming and dysfunction in AML
Kumar, B., Singh, A., Basar, R., Uprety, N., Li, Y., Fan, H., Cortes, A. K. N., Kaplan, M., Acharya, S., Shaim, H., Xu, A. C., Wu, M., Ensley, E., Fang, D., Banerjee, P. P., Garcia, L. M., Tiberti, S., Lin, P., Rafei, H. & Munir, M. N. & 30 others, , Sep 11 2024, In: Science translational medicine. 16, 764, eadp0004.Research output: Contribution to journal › Article › peer-review
Open Access23 Link opens in a new tab Scopus citations